Introduction
Iron is a cofactor for enzymatic reactions and is required for the transport of oxygen. Increased concentrations of free iron are toxic by forming reactive byproducts (Rouault et al., 1987) and free iron also seems to mediate the cytotoxic effects of nitric oxide (Desole et al., 1998) . To maintain iron in a soluble and readily available form, it is intracellularly bound to ferritin. This iron storage complex consists of 24 subunits composed of varying numbers of a light-chain (L-) ferritin and a heavy-chain (H-) ferritin, which also preserves the cell from the toxicity of free iron and, therefore, iron-influx induces ferritin expression.
The higher the proportion of L-ferritin (basic ferritin), the more the complex is utilized as an iron long-term store, and the higher the H-ferritin content within the ferritin complex (acidic ferritin), the more this ferritin is assumed to play a key role in the intracellular traffic of iron to assist enzymatic processes (Lawson et al., 1991) . This implicates that iron storage and particularly Hferritin have to be tightly regulated. In this respect, it is noteworthy that the c-Myc:Max heterodimeric transcription factor, which is required for G1-entry, directly repressed H-ferritin mRNA transcription through interaction with the initiator element (Inr) sequence located within the 5 0 promoter region of the H-ferritin gene (Wu et al., 1999) . This presumably releases iron, which is needed in enzymatic reactions such as the activation of the S-phase relevant ribonucleotide reductase (RR). Besides the regulation of H-ferritin by hemin (Lin and Girotti, 1998) and c-Myc:Max (Wu et al., 1999) , it was demonstrated that H-ferritin also became upregulated by TNFa (Wei et al., 1990; Miller et al., 1991) and IL-1a in an iron-independent manner . Thus, these proapoptotic and differentiation-inducing cytokines influenced iron metabolism directly across H-ferritin, whereas TGF, which also induces differentiation, did not affect H-ferritin expression (Pang et al., 1996) . Therefore, H-ferritin regulation by TNFa is most likely not correlated with differentiation, but with apoptosis.
Transferrin, which is essentially synthesized in hepatocytes, is involved in the transport of plasma iron into the cell and was shown to play a role in cell differentiation and proliferation. Neoplastic cells were reported to express high levels of transferrin receptor (CD71) and internalize iron from transferrin at a very high rate, because growing cells have an increased requirement for iron. It was described that mammalian cell lines rapidly die after transferrin depletion (Barnes and Sato, 1979) . This, however, seems to be specific for some, but not all cell lines. In contrast, a number of cell lines as well as normal human fibroblasts and primary human ovarian carcinoma cells stay viable for several days and even weeks when serum and transferrin are withdrawn. Hence, transferrin limitation per se is not necessarily an apoptotic trigger. It was shown that the human ovarian carcinoma cell line N.1 underwent autocrine, TNFa-mediated apoptosis when serum was withdrawn and that this was dependent on c-Myc expression . In the presence of serum, which contains nonidentified survival factors and transferrin, however, neither Myc-activation or TNFa treatment nor exposure to oncolytic agents induced apoptosis Fuhrmann et al., 1999; Rosenberger et al., 2000) . This makes the identification of specific survival factors a prime task. Many human ovarian carcinomas produce TNFa (Naylor et al., 1993) and therefore N.1 cells are a relevant model to study ovarian tumor biology. Therefore, we investigated the regulation and the role of Hferritin in response to Myc-activation and TNFa treatment under serum-free, proapoptotic conditions, and identified transferrin as a survival factor in the human N.1 and HTB77 ovarian carcinoma lines and in primary human ovarian carcinoma cells.
Results

Indirect upregulation of H-ferritin by Myc:ER activation
In the N.1 human ovarian carcinoma cell line, apoptosis is well defined and a number of physiologic and synthetic cytotoxic compounds were studied Grusch et al., 1999; Rosenberger et al., 2000) . It was shown previously that in N.1-Myc:ER cells, treatment with 4-hydroxytamoxifen (4-OHT) caused a shuttle of Myc:ER from the cytoplasm into the nucleus, which triggered apoptosis in serum-free medium , whereas 4-OHT in the presence of 10% FCS rendered N.1-Myc:ER cells to also grow in suspension (data not shown).
Here we analysed the regulation of H-ferritin in N.1 human ovarian carcinoma cells under serum-depleted (0% FCS) and serum-rich (10% FCS) conditions after the activation of a Myc:ER chimera.
In the absence of serum, 4-OHT induced apoptosis and upregulated H-ferritin mRNA levels, which were highest after 48 and 72 h (Figure 1a) , whereas in the presence of 10% FCS, 4-OHT upregulated H-ferritin mRNA levels only slightly ( Figure 1b ) and apoptosis was inhibited. A downregulation of H-ferritin in the presence of 10% FCS, as observed in immortalized CBB lymphocytes (Wu et al., 1999) , was not observed in N.1 cells after Myc:ER activation. The kinetic of the timedependent upregulation, when serum was withdrawn, suggested that the H-ferritin gene was not a direct target of the Myc transcription factor in N.1-Myc:ER cells, but required intermediate protein synthesis, which was confirmed by cycloheximide (CX) experiments (Figure 1c) . The reason for the difference in the basal levels of H-ferritin mRNA expression in Figure 1a versus Figure 1c is the longer exposure time of the membrane shown in Figure 1c to the UV film to demonstrate the decrease of H-ferritin expression, whereas the membrane shown in Figure 1a was exposed for a shorter time to demonstrate the increase in H-ferritin mRNA expression.
Induction of apoptosis by iron sequestration
Next, it was tested whether intracellular iron chelation might generate an apoptotic stimulus. The iron complexer deferoxamine (DF; 50 mM final concentration) induced Figure 1 Expression of H-ferritin mRNA upon Myc-activation in pooled N.1-Myc:ER cells under serum-depleted (0% FCS) and serum-rich (10% FCS) conditions. (a) Pooled N.1 Myc:ER cells were grown to 20% confluence in medium containing 10% FCS, then serum was withdrawn (0% FCS) and after further 24 h 750 nM 4-OHT was added in the absence of FCS. Cells were harvested after 2, 6, 24, 48, and 72 h. (b) Pooled N.1 Myc:ER cells were grown in 10% FCS to 20% confluence. Then cells were exposed to 750 nM 4-OHT in the presence of 10% FCS for 2, 6, 24, 48, and 72 h. Densitometer readings of H-ferritin mRNA expression giving the fold induction over control normalized to GAPDH expression: FCS) . Pooled N.1 Myc:ER cells were grown to 20% confluence in medium containing 10% FCS, then serum was withdrawn and after further 24 h 750 nM 4-OHT, 750 nM 4-OHT and 10 mg/ml CX, or CX alone were added. Cells were lysed and total RNA was isolated, separated by electrophoresis, transferred on Immobilon S, and analysed by hybridization to Hferritin. Thereafter, the membrane was stripped and rehybridized against GAPDH to confirm equal sample loading (a, b, c) Transferrin is a general inhibitor of apoptosis S Fassl et al the apoptosis of N.1-Myc:ER cells. The viability of these cells was only marginally reduced in combination with 4-OHT after 72 h of cotreatment (Figure 2a, b) . Since pharmacological iron depletion induced apoptosis, the ectopic overexpression of H-ferritin was tested ( Figure 2c ). Firstly, the doubling time of a pooled N.1-Myc:ER-H-ferritin clone was calculated and compared with an appropriate control clone (N.1-Myc: ER þ pBABE-hygro) under serum-rich conditions. Whereas the mock-transfected control clone doubled within 16 h, the N.1-Myc:ER-H-ferritin clone required 20 h for cell duplication. This was in agreement with the hypothesis (Wu et al., 1999) that increased H-ferritin expression chelates free iron required for S phase relevant genes and thus, decreases cell cycle progression. Hence, H-ferritin overexpression seemed functional because the H-ferritin overexpressing pooled N.1 clone exhibited the phenotype that was anticipated. After induction with 4-OHT under serum-free conditions, the apoptosis rate of the pooled N.1-Myc:ER-Hferritin clone was increased when compared to the mock-control (Figure 3a) . Thus, the deregulation of the iron metabolism, by treatment with DF or by Myc-induced upregulation of H-ferritin with 4-OHT, influenced an apoptotic mechanism in N.1 cells.
Protection from Myc:Er induced apoptosis by holotransferrin
If iron depletion was the cause for apoptosis, we speculated that the replenishment of the iron pool, by supplementing the cell culture medium (0% FCS) with transferrin, should prevent apoptosis. In fact, addition of 10 mg/ml of holo-transferrin rescued N.1-Myc:ERcontrol cells and N.1-Myc:ER-H-ferritin cells from 4-OHT-induced apoptosis (Figure 3a, b) .
Therefore, holo-transferrin could mimic the apoptosispreventive effect of 10% FCS and has to be considered a survival factor in N.1 ovarian carcinoma cells, and similar to 10% FCS transferrin, also inhibited H-ferritin upregulation by 4-OHT (Figure 3c ). Other factors, which are well known to promote survival in other cell systems, such as EGF, IGF-1, PDGF, and FGF did not inhibit the apoptosis of N.1 cells (data not shown).
To further confirm that iron-charged transferrin was apoptosis-protective, N.1-Myc:ER cells were serumstarved for 24 h, then exposed to increasing concentrations of holo-transferrin and apo-transferrin (respectively) for 5 h, and then 4-OHT was added for 48 h. Figure 3d shows that 7 and 15 mg/ml holo-transferrin blocked apoptosis more efficiently than identical concentrations of apotransferrin. The weak antiapoptotic effect of 7 mg/ml apotransferrin (which was not significant) might have been due to the recharging of apotransferrin with iron released from dead and therefore leaking cells.
Protection from physiologically induced apoptosis by holo-transferrin
Physiologic inducers of apoptosis, such as TNFa, FasL, and TRAIL were tested and H-ferritin mRNA expression was analysed (Figure 4a, b) . After treatment of N.1 ovarian carcinoma cells with TNFa, FasL, and TRAIL for 72 h, the expression of H-ferritin was increased under serum-free culture conditions (0% FCS), at which N.1 cells underwent apoptosis (Figure 4a ). At high serum concentrations (10% FCS), however, at which N.1 cells were refractory to FasL-, TNFa-and TRAILinduced apoptosis, H-ferritin mRNA did not become upregulated (Figure 4b ). Treatment with 4-OHT, TNFa, FasL, and TRAIL also resulted in an increase in Hferritin protein levels (Figure 4c ).
When iron was limited (0% FCS), treatment of N.1 cells with TNFa, FasL, and TRAIL increased CD71- levels with distinct kinetics (with regard to the inducers) and the supplementation with holo-transferrin suppressed only TRAIL-induced CD71 induction, but not the one induced by TNFa or FasL (Figure 4d ). To specify whether transferrin prevents apoptosis in death ligand-induced apoptosis and whether or not this effect depends on iron, serum-deprived N.1 cells were preexposed to holo-and apo-transferrin and to Fe 2 þ SO 4 and after 5 h TNFa was added and experiments were terminated after 96 h (Figure 4e ). Whereas holo-transferrin efficiently promoted the survival of TNFa-treated N.1 cells, apo-transferrin had almost no effect. Fe 2 þ SO 4 slightly improved the survival rate of N.1 cells (Figure 4e ). We assume that free iron is insufficiently taken up by N.1 cells. To prove formally that the cytoprotective effect of holo-transferrin was due to the inhibition of apoptosis, the TNFa-experiment was repeated in the presence of increasing concentrations (5, 10, 15, 20 mg/ml) of apo-and holo-transferrin and analysed by HO/PI staining ( Figure 4f ). Also FasL-and TRAIL-induced apoptosis of N.1 cells was inhibited by holo-transferrin ( Figure 5a ). The testing of other ovarian carcinoma cell lines showed that in TR170 and M134 cells, TNFa-induced apoptosis was not prevented by holo-transferrin (data not shown) and in HTB-77 cells TNFa was a growth factor (data not shown). However, the viability of FasL-treated HTB-77 cells was increased by 2 and 5 mg/ml holo-transferrin ( Figure 5b ), and 10 mg/ml holo-transferrin (or 100 ng/ml PDGF, but not by IGF-1; data not shown) improved the ) conditions. Pooled N.1 Myc:ER cells were grown in 10% FCS. Serum was withdrawn and after 24 h TF (10 mg/ ml) was added and after further 5 h active cell death was induced by the addition of 750 nM 4-OHT. Cells were harvested after 24 and 48 h, lysed and total RNA was isolated, separated by electrophoresis, transferred on to Immobilon S, and analysed by hybridization to H-ferritin. Thereafter, the membrane was stripped and rehybridized against GAPDH to confirm equal sample loading. (d) N.1-Myc:ER cells were grown to 20% confluence, then serum was withdrawn for 24 h, and then cells were exposed to increasing concentrations of apo-and holo-TF (2 , 7 , 15 mg/ml, respectively). After 5 h of TF-pretreatment, 4-OHT (750 nM final concentration) was added for 48 h. Then, floating cells and attached cells were harvested, pooled, and analysed by the HO/PI assay. Mean values of triplicate experiments are shown. Error bars indicate s.e. Statistical analysis by the t-test: Differences between 4-OHT control (0 mg/ml TF) versus 4-OHT þ 2 mg TF (apo; holo) are not significant (NS):
4-OHT versus 4-OHT þ 7 mg/ml holo-TF, P ¼ 0.0199 (s); 4-OHT versus 4-OHT þ 15 mg/ml holo-TF, P ¼ 0.0167 (s); 4-OHT versus 4-OHT þ 7 mg/ml apo-TF, P ¼ 0.0865 (NS); 4-OHT versus 4-OHT þ 15 mg/ml apo-TF, P ¼ 0.63 (NS); 4-OHT þ 7 mg/ml apo-TF versus 4-OHT þ 7 mg/ml holo-TF, P ¼ 0.0436 (s); 4-OHT þ 15 mg/ml apo-TF versus 4-OHT þ 15 mg/ml holo-TF,
Transferrin is a general inhibitor of apoptosis S Fassl et al survival of TRAIL-treated PA-1 cells. This implicates that (i) holo-transferrin was a survival factor for N.1, HTB-77 and PA-1 human ovarian carcinoma cells; (ii) proapoptotic ligands induced apoptosis by a pathway involving iron regulation mechanisms.
Holo-transferrin protects primary human ovarian carcinoma cells from ligand-induced apoptosis
Human ovarian carcinoma cells isolated from ascites fluids of distinct patients (ascites I, II, III) were seeded in triplicate on poly-D-lysine-or noncoated cell culture dishes. Case(I). At 2 weeks after seeding ascites-I cells, serum was withdrawn and TNFa was added (60 ng/ml final concentration), which reduced the viability to 66.2% after 120 h of treatment. In the presence of 10 mg/ml holo-transferrin or 100 ng/ml EGF, 88.6 and 80.2% of the cells remained viable, respectively ( Figure 5c ). PDGF slightly reduced the viability to 58.9% (data not shown). This demonstrates that holo-transferrin and also EGF are survival factors in primary human ovarian carcinoma cells.
Case(II). At 3 weeks after seeding ascites-II cells, serum was withdrawn and where indicated (Figure 5d) , 5 m or 20 mg/ml transferrin was added. After 5 h, 100 ng/ ml TNFa or 25 ng/ml FasL was applied for 120 h, respectively. Then, cells that remained attached to the substratum (viable cells) were harvested and counted. TNFa reduced the viability to 53.9%, and together with holo-transferrin viability, increased to 66.0%. FasL reduced the viability to 40.3%, and together with holotransferrin viability, increased to 50.3% (Figure 5d ).
Case(III). Cells derived from ascites-III were directly seeded into serum-free medium, and where indicated (Figure 5e ), 20 mg/ml holo-transferrin was added. After 5 h, cells were exposed to 50 ng/ml TNFa, 25 ng/ml FasL, or 40 ng/ml TRAIL, respectively, for 120 h. Then the percentage of apoptotic cells was determined by HO/PI double staining. The spontaneous apoptosis rate of controls was 5.2% and TNFa, FasL, and TRAIL induced 14.3, 16.5, and 23.1% apoptosis, respectively. Transferrin reduced this rate to 10.4, 6.7, and 9.7%, respectively. This corresponded to a transferrinmediated repression of apoptosis of: 43% (in case of TNFa-induction), 87% (in case of FasL-induction), and of 75% (in case of TRAIL-induction), when spontaneous apoptosis rates of controls were subtracted.
Discussion
Besides oxygen transport in platelets, iron is required as a cofactor in various physiological enzyme reactions such as the activation of ribonucleotide reductase (RR), which is required in dNTP synthesis during the S-phase (Szekeres et al., 1997; Wu et al., 1999) . Therefore, it is widely accepted that transferrin promotes cell proliferation. It was discussed that Myc-dependent downregulation of H-ferritin might release bound iron to support RR-activation. This is consistent with the role of c-Myc in the induction of proliferation when serum factors (survival factors) are present (Evan et al., 1992; Harrington et al., 1994) . This prompted us to test how iron-regulatory proteins become affected during Mycinduced apoptosis and whether transferrin modulates apoptosis in the absence of serum factors.
The data presented here demonstrate that (a) Myc:ER-activation by 4-OHT triggered upregulation of H-ferritin expression under serum-depleted conditions and induced apoptosis. (b) Myc:ER-induced apoptosis and H-ferritin upregulation as well as TNFa-, FasL-, and TRAILinduced H-ferritin upregulation and apoptosis was inhibited by serum or transferrin. (c) Transferrin-mediated survival was dependent on its iron charge, which suggests that apoptosis of N.1 cells was tightly connected with the dysregulation of intracellular iron homeostasis. Moreover, DF induced apoptosis in N.1 cells. (d) TNFa-, FasL-, and TRAIL-induced cell death of human primary ovarian carcinoma cells was also inhibited by holo-transferrin.
Transferrin, as serum, inhibited IL-2-induced apoptosis in human T-blasts (Shi et al., 1997) , thereby demonstrating the survival-promoting effect. Distinct mechanisms seem to account for transferrin-mediated survival, because it was shown that apoptosis of marrow cells elicited by girradiation, TNFa, or agonistic Fas antibody was prevented by glycosylated transferrin and by transferrinderived glycans, and not, however, by deglycosylated transferrin or glycans derived from other sources. This implicates that a transferrin-related survival effect was independent of iron, of the transferrin protein core, and of the receptor CD71 (Lesnikov et al., 2001) . Also, ironindependent growth promotion of HL-60 cells by transferrin was demonstrated (Leung et al., 1993) and transferrin receptor activation with specific antibodies (therefore iron-independent) stimulated tyrosine phosphorylation of TCR and growth in T-cells (Salmeron et al., 1995) . In contrast, blocking CD71 by monoclonal antibodies evidenced that transferrin receptor activity is necessary to prevent iron deprivation-induced apoptosis of 38C13 lymphoma cells (Kovar et al., 1997) . Depleting intracellular iron in human leukemia cells by DF caused apoptosis, which was prevented by ferric chloride (Kyriakou et al., 1998) , similar to ferric citrate-inhibited apoptosis in response to DF treatment of 38C13 lymphoma cells (Kovar et al., 1997) . Enhanced iron uptake promoted the survival of erythroid progenitor cells (Honda et al., 2001) , whereas loss of iron led to a marked reduction in ATP production and to cell death in myeloid cells (Maclean et al., 2001) . Iron chelation by pyridoxal isonicotinoyl hydrazone analogues triggered apoptosis in Jurkat T and K562 cells (Buss et al., 2003) and iron chelation by DF induced apoptosis of HL-60 cells, which was accompanied by dysregulation of the cell cycle regulatory genes c-Myc, Rb, p21, and cyclins A, D3, and E1 (Alcantara et al., 2001) . Furthermore, Ara-C-induced apoptosis of myeloid leukemic cells was potentiated by DF (Leardi et al., 1998) . Not only hematopoietic cells are iron-sensitive because transferrin promoted the survival of human lens epithelial cells also (Davidson et al., 1998) . Neuroblastoma cells died upon iron depletion (Richardson and Milnes, 1997) , and DF-induced teratocarcinoma F9 cell death was inhibited by Fe 3 þ -ions (Tanaka et al., 1997) . On the other hand, in corpora luteal (CL) cells transferrin did not prevent apoptosis induced by simultaneous exposure to agonistic Fas antibody þ interferon þ TNFa (Quirk et al., 2000) . Therefore, in CL cells ligand-induced apoptosis did not seem to be triggered by the affected intracellular iron homeostasis but was most likely elicited by direct activation of caspase cascades typical for the Fas and TNF-receptor pathways.
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Although some cancer cell lines depend on iron in their culture media others are independent of iron for survival (Kovar et al., 2001) . This is in agreement with the data presented here, demonstrating that holotransferrin was not required to ensure the survival of unstimulated N.1 cells, but only to prevent apoptosis that was stimulated by ligands or Myc. Fe 2 þ SO 4 had only a minor protective effect in N.1 cells, probably due to inpermeabilty of the outer membrane, and apo-transferrin was also ineffective. Therefore, rescue seemed to depend on receptor-mediated iron uptake.
In contrast, it was shown that DF prevented the apoptosis of primary mouse fibroblasts, which were induced to apoptose by serum deprivation (Ferris et al., 1999) . Some reports describe that excess iron, which reacts with oxygen and generates cytotoxic reactive oxygen byproducts, induced apoptosis that was inhibited by DF-mediated iron chelation (Rollet-Labelle et al., 1998; Vollgraf et al., 1999) . Therefore, iron overload as well as iron depletion can induce programmed cell death, albeit by distinct mechanisms of induction.
Since holo-transferrin protected primary ovarian carcinoma cells from cell death, iron depletion rather than iron overload was the trigger in this cell type.
The pronounced upregulation of H-ferritin in response to Myc:ER. activation in N.1 cells implicates that the availability of iron, which is required for the activation of proliferation-relevant enzymes (Wu et al., 1999) , became limited and this may explain the dual role of c-Myc in the induction of cell proliferation and of apoptosis (Thompson, 1998; Fuhrmann et al., 1999) , Figure 4 Expression of H-ferritin mRNA after TRAIL, FasL, and TNFa treatment in pooled N.1-Myc:ER cells. Pooled N.1 Myc:ER cells were grown to 20% confluence in medium containing 10% FCS. (a) Then serum was withdrawn for 24 h and TNFa (40 ng/ml), TRAIL (75 ng/ml; enhancer: 1 mg/ml)) and FasL (75 ng/ml; enhancer: 1 mg/ml) were added subsequently; or (b) these apoptosis inducers were added directly to cell cultures containing 10% FCS. After 72 h (a, b), cells were lysed and total RNA was isolated, separated by electrophoresis, transferred on to Immobilon S, and analysed by hybridization to H-ferritin. Thereafter, the membrane was stripped and rehybridized against GAPDH to confirm equal sample loading (a, b). (d) Expression of CD71 (transferrin receptor) in N.1 cells. Cells were grown to 20% confluence in culture medium containing 10% FCS. Then serum was withdrawn and substituted for transferrin (TF; 10 mg/ml), where indicated. After 5 h, N.1 cells were exposed to TNFa (40 ng/ml), FasL (75 ng/ml þ enhancer), and TRAIL (75 ng/ml þ enhancer), and treated for 8, 48, 72, and 96 h. Then, total protein was isolated and separated on SDS-polyacrylamide gels, transferred onto PVDF membranes, and immunoblotted with anti-CD71 antibody. Equal loading was confirmed by staining with Poinceau S (not shown). (e) Survival rates of TNFa-stimulated parental N.1 cells depending on iron. Equal numbers of cells were grown to 20% confluence in culture medium containing 10% FCS. Then serum was withdrawn and substituted for 5 mg/ml holo-transferrin (holo-TF), 5 mg/ml apo-transferrin (apo-TF), or 350 nM Fe 2 þ SO 4 , where indicated. After 5 h, 50 ng/ml TNFa was added and cells that remained attached were harvested after 96 h and counted. Mean values of three independent experiments are shown. Error bars indicate s.e.
Statistical analysis by the t-test:
N.1 cells treated with TNFa versus TNFa þ holo-TF, P ¼ 0.0012 (s); TNFa þ holo-TF versus TNFa þ apo-TF, P ¼ 0.0054 (s); TNFa versus TNFa þ Fe 2 þ SO 4 , P ¼ 0.1504 (NS).
(f) Apoptosis rates of TNFa-stimulated N.1 parental cells depending on apo-and holo-TF. Equal numbers of cells were grown to 20% confluence in culture medium containing 10% FCS, then serum was withdrawn for 24 h and then the cells were exposed to increasing concentrations of apoand holo-TF (5, 10, 15, 20 mg/ml, respectively). After 5 h of TF-pretreatment, TNFa (40 ng/ml final concentration) was added for 72 h. Then, floating cells and attached cells were harvested, pooled, and analysed by the HO/PI assay. Mean values of triplicate experiments are shown. Error bars indicate s.e.
TNFa þ holo-TF versus TNFa þ apo-TF (5 mg/ml), P ¼ 0.0002 (s); TNFa þ holo-TF versus TNFa þ apo-TF (10 mg/ml), Po0.0001 (s); TNFa þ holo-TF versus TNFa þ apo-TF (15 mg/ml), Po0.0001 (s); TNFa þ holo-TF versus TNFa þ apo-TF (20 mg /ml), Po0.0001 (s)
Transferrin is a general inhibitor of apoptosis S Fassl et al depending on the presence or absence of survival factors, respectively. Upon serum withdrawal, N.1 cells downregulated H-ferritin expression and these cells remained viable for weeks. Since serum depletion causes the interruption of extracellular iron supply (i.e. through the lack of holotransferrin), the residual intracellular iron has to be available for resuming cellular processes, which can be accomplished by the downregulation of H-ferritin. As soon as H-ferritin expression became induced (i.e. by TNFa, FasL, TRAIL, or 4-OHT) in the situation of insufficient extracellular iron replenishment (in serumfree culture conditions), this may have caused the resequestration of the residual intracellular free iron required for yet undefined survival processes. The correlation between H-ferritin upregulation and an apoptosis-prone cellular state was supported by experiments with N.1 cells, which stably overexpressed ectopic H-ferritin cDNA. These cells exhibited an enhanced apoptosis rate when induced with 4-OHT, which was prevented by transferrin. Therefore, not H-ferritinupregulation itself, but intracellular iron sequestration in the face of an iron-depleted extracellular environment seemed to be the trigger for cell death. This hypothesis was supported by the proapoptotic effect of the intracellular iron chelator DF, and by the antiapoptotic effect of holo-transferrin, which most likely restored intracellular iron homeostasis. Notably, apo-transferrin failed to prevent apoptosis of N.1 cells. It was shown that apoptotic macrophages exhibited high ferritin levels (Yuan, 1999) and during mammary gland involution, which is characterized by epithelial cell death, H-ferritin was induced (Baik et al., 1998) . In fibroblasts derived from patients with Werner's syndrome, who have a severely shortened lifespan, H-ferritin was overexpressed (Murano et al., 1991) .
It was reported earlier by others that H-ferritin became induced by TNFa in human fibroblasts and muscle cells (Wei et al., 1990; Tsuji et al., 1991 ) and here we demonstrate that TNFa and also TRAIL, FasL, and agonistic Fas-antibody upregulated H-ferritin expression in N.1 human ovarian cancer cells. Therefore, these ligands disturb iron homeostasis and this might contribute to the elicitation of a cell death program. The addition of holo-transferrin, which stabilizes the intracellular iron pool, abrogated TNFainduced cell death and also apoptosis induced by TRAIL and FasL.
The upregulation of CD71 in response to proapoptotic ligands, which itself induced H-ferritin, was anticipated because as a rule in most nonerythroid cell types CD71 levels increase when intracellular iron is low (e.g. when H-ferritin is high) and vice versa (Lok and Loh, 1998) . The regulation of CD71 in TNFa-and FasLtreated N.1 cells was similar under serum-depleted (proapoptotic) conditions and under transferrin-supplemented (antiapoptotic) conditions. Therefore, apoptosis triggered by TNFa, FasL, or TRAIL did not correlate with CD71 expression, and the unexpected lack of CD71-regulation upon exposure to antiapoptotic concentrations of holo-transferrin suggests that the antiapoptotic signal of holo-transferrin might have been transduced by a mechanism different from CD71. Recently, a homologue of CD71, transferrin receptor 2 (TfR-2), was discovered, which binds to holo-transferrin, regulates iron homeostasis, but seems to exert unique functions (Kawabata et al., 2001a) . Interestingly, TfR-2 expression is high in early erythroid precursor cells, which need to be protected from apoptosis, and decreases during differentiation (Kawabata et al., 2001b) . The data evidence that the activation of Myc:ER indirectly upregulated H-ferritin in N.1 cells. This stands in contradiction to the finding that c-Myc directly repressed H-ferritin transcription through an Inr sequence in the H-ferritin promoter in genetically altered B-lymphocytes, Rat 1 fibroblasts, and CV-1 monkey cells. In these cells, Myc was reported to be ectopically overexpressed in large amounts, which might have disturbed a physiological equilibrium of a variety of expressed proteins (Wu et al., 1999) . This circumstance, or the cell types used in this study, might express proteins (which in contrast may not be expressed in N.1 cells), which promote the binding of Myc-Max dimers to this Inr sequence, or alternatively, may promote the presentation of this sequence. Hferritin (À/À) mice die early in embryonic development (Ferreira et al., 2001) , whereas Myc-transgenic mice develop to cancer-prone animals. Therefore, in the case that Myc directly downregulates H-ferritin under physiological conditions, this does not seem to occur in all, but only in some cell types, otherwise Myc transgenic mice should also die during embryogenesis (in contrast, in H-ferritin knockout mice all cells are affected). (b) HTB-77 cells were grown to 30% confluence in medium containing 10% FCS, then serum was withdrawn. At 24 h after serum deprivation, TF (2 mg/ml; 5 mg/ml) was added and after 5 h FasL (50 ng/ml) was added for 72 h. Cells remaining attached to the culture dish were trypsinized and counted. Mean values of duplicate experiments are shown. Error bars indicate s.e. (c) Equal numbers of ovarian carcinoma ascites cells from patient I were cultivated on poly-D-lysine-coated 24-well plates. Then serum was withdrawn for 24 h and saline (Co), 60 ng/ml TNFa,710 mg/ml TF (given 5 h before TNFa), or 100 ng/ml epidermal growth factor (EGF; given 5 h before EGF) was added. After 120 h, cells that remained attached to the culture plates were trypsinized and counted. Trypan blue exclusion confirmed that attached cells had intact membranes, whereas cells that floated in the culture supernatant stained blue. Mean values of three independent experiments are shown. Error bars indicate s.e.
Ascites I cells treated with TNFa versus TNFa þ holo-TF, P=0.0051 (s); TNFa versus TNFa þ EGF, P=0.0387 (s).
(d) Equal numbers of ovarian carcinoma ascites cells from patient II were seeded into culture medium containing 10% FCS and allowed to attach to the culture wells. Then serum was withdrawn and where indicated, substituted for TF (5 mg/ml, 20 mg/ml). After 5 h, cells were exposed to 100 ng/ml TNFa and 25 ng/ml FasL. After 120 h, cells that retained attached were trypsinized and counted. Mean values of triplicate experiments are shown. Error bars indicate s.e.
Ascites II cells treated with TNFa versus TNFa þ holo-TF, Po0.0001 (s); FasL versus FasL þ holo-TF, P ¼ 0.0090 (s).
(e) Equal numbers of ovarian carcinoma ascites cells from patient III were seeded into culture wells. Since these cells hardly attached to the culture device, they were plated directly into serum-free medium and TF (20 mg/ml) was added where indicated. After 5 h, 50 ng/ml TNFa, 25 ng/ ml FasL, and 40 ng/ml TRAIL were added, respectively. Cells were harvested after 120 h, stained with Hoechst 33258/PI (final concentrations 5 mg/ml : 2 mg/ml, respectively), and photographed through a DAPI filter connected to a Zeiss Axiovert microscope. Mean values of three independent experiments are shown. Error bars indicate s.e.
Ascites III cells treated with TNFa versus TNFa þ holo-TF, P ¼ 0.1173 (NS); FasL versus FasL þ holo-TF, P ¼ 0.0089 (s); TRAIL versus TRAIL þ holo-TF, Po0.0001 (s)
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In former investigations, it was shown that N.1 cells secreted TNFa, which induced apoptosis in an autocrine manner under specific, serum-limited experimental conditions . Bast and colleagues found that TNFa is a growth factor for normal and malignant human ovarian epithelial cells (Wu et al., 1992 (Wu et al., , 1993 under serum-rich culture conditions. This reminds us of the dual role of c-Myc, which promotes proliferation in presence of serum factors, whereas it induces apoptosis when serum is withdrawn (Harrington et al., 1994) . In fact, TNFainduced apoptosis was demonstrated to depend on the activity of c-Myc (Klefstrom et al., 1994; Simonitsch and Krupitza, 1998) .
It was shown that Myc-induced apoptosis was inhibited by IGF-1 or PDGF in rat 1 cells (Evan et al., 1992; Harrington et al., 1994) or by IL-3 in myeloid cells (Askew et al., 1991) . IGF-1 and PDGF were demonstrated to activate PI.3-kinase and in turn Akt, which is a prominent component of a survival pathway (Kauffmann-Zeh et al., 1997). This pathway seems to be rather ineffective in N.1 cells, because inhibition of PI.3 kinase with increasing concentrations of LY 294002 (10, 20, 40 mM) had no apoptosis-modulating effect during Myc activation (under 0% FCS) and neither IGF-1, nor PDGF or EGF was protective (data not shown). In engineered CHO cells, IGF-1 (but not transferrin) ensured survival when serum was withdrawn, whereas transferrin (but not IGF-1) induced proliferation (Sunstrom et al., 2000) . The addition of holo-transferrin to serum-starved N.1 cells and primary ovarian cancer cells did not induce proliferation (data not shown), which makes autocrine IGF-1 synthesis, as alternative explanation for the survival of N.1 cells, unlikely. Therefore, the survival mechanisms described here for human ovarian carcinoma cells are different from those that rescue Chinese hamster ovary cells from apoptosis.
Since many human ovarian tumors produce TNFa (Naylor et al., 1993) , it is important to identify serum factors, such as transferrin, which prevent TNFainduced apoptosis of ovarian cancer cells.
Methods
Materials
Human H-ferritin cDNA was a kind gift from Dr Mathias Henze (EMBL, Heidelberg), the pBABE-hygro vector and the Myc:ER-pBABEpuro construct were obtained from Dr Trevor Littlewood (ICRF, London) and the pWZL plasmid was obtained from Dr Manuel Serrano (National Center of Biotechnology, Madrid). The Phoenix ecotropic packaging cell line was a gift from Dr Gary P Nolan, (Department of Molecular Pharmacology, Stanford University School of Medicine). The anti H-ferritin (#F-6136; Sigma), and anti CD71 (#MS-239; Neo Markers) antibodies were used for Western blotting. The agonistic Fas antibody (clone CH-11) was obtained from BioMol, TNFa, FasL, and TRAIL were obtained from Alexis, and enhancer antibody (anti flag-tag ab), deferoxamine, 4-hydroxytamoxifen (4-OHT), IGF-1, PDGF-AB, apo-, and holo-transferrin were obtained from Sigma and EGF was from Collaborative Research.
Subcloning procedures
The H-ferritin or egfp (for control reasons) cDNA was subcloned into the SnaBI site of pBabeHygro and propagated in E.coli JM109.
Cell culture
(1) The monoclonal human ovarian adenocarcinoma N.1 cell line is a derivative of the heterogeneous HOC-7 cell line, which was cultured in minimal essential medium (MEM) supplemented with 10% FCS (Gibco), and penicillinstreptomycin (100 U/ml-100 mg/ml, Gibco) (medium A), at 371C in a humidified atmosphere containing 5% CO 2 . Loss of estrogen receptor (ER) function is typical for ovarian carcinomas and ovarian carcinoma cell lines (Slotman and Rao, 1988; Hua et al., 1995) . Exposure to 10 mM estradiol neither induced apoptosis nor altered constitutive H-ferritin mRNA expression. Cyclin D1, which harbors an estrogen response element in its promoter region, was neither induced by estradiol nor by 4-OHT. Thus, N.1 cells did not express functional estrogen receptor and this qualified N.1 cells to be used in investigating apoptosis with the 4-OHT-inducible Myc:ER construct. 
Cultivation of human ovarian carcinoma cells from ascites
Ascites fluid (800 ml) was centrifuged and cells were collected and cultivated in Iscoves medium (Gibco), 20% FCS, penicillin/streptavidin, EGF, and IGF (100 ng/ml each) on poly-D-lysine-coated 24-well culture dishes (Becton and Dickinson). Cells were passaged three times, thereby ridding off mesothelial cells. CA125 analysis confirmed that cultures consisted of ovarian carcinoma cells.
Transfection of cells
N.1 cells were plated into 60 mm dishes and grown for 2 days to 40-50% confluence. Lipofection of cells with pWZL cDNA (pWZL is an ecotropic mouse retrovirus receptor) was performed utilizing the Transfectam reagent (Promega). The cells were washed once with prewarmed MEM without FCS. A measure of 5 mg DNA (1 mg/ml) and 10 ml transfectam were separately pipetted into 0.75 ml MEM each and then both mixtures were combined. Transfectam-DNA complexes were allowed to form for 10 min and were then applied onto N.1-cells for 3 h in a humidified incubator. The transfection was stopped by adding 4 ml MEM containing 10% FCS. The next day, the cells were split into new dishes with fresh medium, and 48 h after transfection 500 mg/ml G-418 was added for selection. After 10-14 days, G-418 concentration was reduced to 200 mg/ml and single clones (N.1-pWZL) were isolated with cloning cylinders and were propagated separately.
Generation of ecotropic mouse retrovirus transducible N.1 human ovarian carcinoma cells N.1-pWZL single clones were infected with an ecotropic mouse retrovirus containing the EGFP gene. Those clones, which expressed functional pWZL (identified by green fluorescence when inspected under UV-light in conjunction with a FITC-filter), were pooled and used for control reasons. The parental clones, which were identified by this assay (N.1-pWZL) to express functional retrovirus receptor, were also pooled and this pooled clone was subsequently infected with an ectopic mouse retrovirus containing Myc:ER. (N.1-Myc:ER cells). This procedure generated several independent Myc:ER-puromycin resistant pools, which were tested with 4-OHT. Functional pools were pooled again (N.1-Myc:ERpool). This pool was postinfected with retrovirus containing H-ferritin (N.1-Myc:ER-H-ferritin pool). Hygromycin-resistant pools were tested by Northern blot and Western blot analyses.
Production of retrovirus titer
Phoenix cells were grown in 100 mm dishes in DMEM, supplemented with 10% FCS and 50 mg/ml hygromycin B.
The transfection procedure (Transfectam) was upscaled for 100 mm dishes and performed as described in the Promega protocol. The cells were transfected at 80% confluence with 12.5 mg plasmid-DNA (concentration 1 mg/ml) in 37.5 ml Transfectam (1 : 3 ratio w/vol). After 1 h of incubation, the medium was replaced by 10 ml fresh medium with 10% FCS. After 24 h, the medium was replaced with 4 ml of complete medium (10% FCS). At 48 h after transfection, the retrovirus containing cell culture supernatant was filtered (0.22 mm filter), aliquoted, shock-frozen in liquid nitrogen, and stored at À801C.
Infection of cells
N.1-pWZL cells were grown in six-well plates to 50% confluence. A measure of 500 ml virus suspension was mixed with 500 ml MEM, containing 10% FCS. Then Polybrene (Sigma) was added to a final concentration of 4 mg/ml. After an infection period of 3 h in the cell culture incubator, 2 ml of MEM with 10% FCS was added. After 24 h, cells were transferred into larger dishes to allow cell growth. At 48 h after infection, selective medium (1 mg/ml puromycin, Sigma) was added to kill noninfected cells. After 10-12 days of selection, the puromycin concentration was reduced to 0.2 mg/ml. Several independent N.1-Myc:ER, N.1-Myc:ER-H-ferritin and control pools of infected N.1-pWZL cells were used for further experiments.
Western blotting
Cells were grown to 50% confluence in 100 mm dishes, then FCS was withdrawn for the time periods indicated. Control cells were further kept under high serum conditions. Experiments were terminated by washing attached cells twice with ice-cold phosphate-buffered saline (PBS, pH 7.2) and harvesting the monolayer with 200 ml SDS-sample buffer. Protease inhibitors were freshly added to the buffer each time. The final concentrations of protease inhibitors were: 20 mM TPCK (Ntosyl-L-phenylalanine chloromethyl ketone; Roche); 20 mM TLCK (tosyl-L-lysine chloromethyl ketone; Roche) and 10 ng/ml benzamidinchloride (sigma). The viscous samples were sonicated, the protein content was measured with DotMetric (Novus Molecular), and equal amounts of total protein were separated by polyacrylamide gel electrophoresis (PAGE).
Subsequent to the electrophoretic separation, the proteins were electro-blotted onto PVDF-membranes (Hybond, Amersham) overnight at 41C. To confirm equal sample loading, membranes were stained with Poinceau S. After washing with PBS, the membrane was blocked for 1 h (blocking solution: 5% skimmed milk in PBS, 0.5% Tween 20) and washed 3 Â with PBS/Tween 20. The primary antibody was incubated by gently rocking overnight at 41C in blocking solution (antibody dilutions: H-ferritin, 1 : 1000; CD71, 1 : 1000). Then the membrane was washed in blocking solution (1 Â ) and in PBS (2 Â ), and further incubated with the second antibody (peroxidase coupled goat anti-rabbit IgG, dilution 1 : 2000-1 : 5000 in PBS/Tween 20) for 1-2 h. Chemoluminescence was developed by the ECL detection kit (Amersham) and then the membranes were exposed to Kodak X-OMAT UV films.
Northern blot analysis
The cell culture medium was removed and the cells were washed twice with ice-cold PBS, and subsequently lysed with RNAzol (BioTex). Total RNA (30 mg/lane) was separated on 1% agarose gels containing formaldehyde and transferred on to Immobilon S membranes (Millipore) by the capillary method. Biotinylated probes were allowed to hybridize to filter-bound RNA at 671C overnight. Biotinylation procedures and filter processing were conducted as described (Krupitza et al., 1995) . Filters were then exposed to Kodak X-ray films.
Determination of doubling time
Cells were grown in 60 or 100 mm dishes. Cells were counted during logarithmic growth twice using one of the formularies below. For example, count cells on days 3 and 5 after splitting. Doubling time was determined using the following calculations:
nd ¼ ð1gc2 À 1gc1Þ=1g2 dt ¼ pg=nd where c1 is the first count, c2 is the second count, nd is the number of doublings, between c1 and c2, pg is the period of growth in hours, dt is the doubling time, and lg is the decimal logarithm (to the basis 10).
Cell death experiments and analysis
Apoptotic cell death was induced by stimulation with 4-OHT, FasL, inducing Fas antibody, TRAIL, TNFa, and DF. To determine the number of surviving cells, the individual clones were grown in six-well plates until 20% confluence. After 24 h of serum reduction (0% FCS), apoptosis inducers were added for the times indicated. Surviving cells were trypsinized and pooled with supernatant cells and stained with Hoechst 33258/ propidium iodide (HO/PI; Hoechst: fin. conc. 5 mg/ml and propidium-iodide: fin. conc. 2 mg/ml) to monitor nuclear chromatin condensation and cell death (Rosenberger et al., 2000) using UV-excitation and a DAPI filter. A detailed description regarding the detection of viable, apoptotic, and necrotic cell death by the HO/PI assay has been published (Grusch et al., 2002) . Under all experimental conditions, phase contrast micrographs were taken from the H-ferritin and control clones at the indicated time points using a Zeiss Axiovert microscope and a Kodak TMX 100 film before cells were harvested for further analysis.
Experiments were confirmed by the TUNEL assay and DNA-fragmentation analysis .
When N.1 cells underwent apoptosis they detached from the substratum and then the characteristic chromatin changes became visible when analysed by HO/PI or TUNEL assays.
These chromatin changes were not detectable in cells that were still adherent. Furthermore, N.1 cells that were treated with 4-OHT, TNFa, TRAIL, or FasL did not exhibit a necrotic but only an apoptotic phenotype. Therefore, floating cells were apoptotic and attached cells were viable. This facilitated to limit the performance of HO/PI assays, which are very tedious, and to perform viability assays in which only the adherent cells are counted. The complementarity of the HO/PI and viability assays is exemplified when comparing Figure 3a (B40% apoptotic cells upon treatment with 4-OHT) with Figure 2a (B60% viable cells upon treatment with 4-OHT).
DNA fragmentation assay
Detached cells were collected from cultures grown in T-25 flasks, centrifuged and lysed in 400 ml of a buffer containing 50 mM Tris pH 8.0, 10 mM EDTA, and 0.5% sodium lauryl sarcosine (lysis buffer). The cells, which were still attached (100% in untreated controls), were lysed in 1200 ml of lysis buffer. A volume of 400 ml each of both types of lysates (from attached and detached cells) were treated with 2 ml RNAse A (11 U/ml, USB) for 1 h at 371C, followed by the addition of 10 ml proteinase K (15 mg/ml, Roche) and incubation for another 3 h at 501C. Then equal amounts of phenol : chloroform : isoamyl alcohol (25 : 24 : 1, Sigma) were added and DNA extracted by gentle treatment (wide-bore pipets, no vortexing). After two washes with chloroform-isoamyl alcohol (24 : 1), DNA was precipitated with alcohol, and resuspended in 30 ml TE (10 mM Tris, 1 mM EDTA, pH 7.5) and 2 ml RNAse (2 U/ ml). The DNA content of the lysates of attached and detached cells was measured photometrically, then the lysates derived from attached and detached cells were pooled, and equal amounts of pooled DNA were subjected to separation on 2% agarose gels.
